Literature DB >> 9271354

A mutation in the hamster alpha1B-adrenergic receptor that differentiates two steps in the pathway of receptor internalization.

J Wang1, J Zheng, J L Anderson, M L Toews.   

Abstract

An NP(X)nY motif is highly conserved among G protein-coupled receptors and is similar to an NPXY motif involved in receptor-mediated endocytosis for several non-G protein-coupled receptors. We investigated the role of this motif in alpha1B-adrenergic receptor function and regulation. Y348A alpha1B-adrenergic receptors in which this sequence was mutated from NPIIY to NPIIA were prepared by site-directed mutagenesis and transfected into Chinese hamster ovary cells. Binding of the antagonist prazosin to Y348A receptors was similar to that of wild-type receptors, but affinity of the Y348A receptors for the agonist epinephrine was increased by approximately 10-fold. Despite this increase in agonist binding affinity, the Y348A mutation completely uncoupled the receptors from stimulation of phosphoinositide hydrolysis and mobilization of intracellular Ca2+. Exposure of cells expressing Y348A receptors to the agonist epinephrine resulted in receptor "sequestration," defined as a loss of cell surface receptors accessible to radioligand in binding assays with intact cells on ice, similar to that for the wild-type receptor. In contrast, Y348A receptors did not undergo "endocytosis" into the light vesicle fraction in sucrose density gradient centrifugation assays, as did the wild-type receptor. These results (i) indicate an important role for Tyr348 in coupling the alpha1B-adrenergic receptor to G protein and subsequent effector activation, (ii) provide further evidence that alpha1B-adrenergic receptor internalization can be separated into a sequestration step and an endocytosis step, (iii) indicate that effector activation and second messenger formation are not required for the sequestration of these receptors but may be involved in endocytosis, and (iv) provide a useful new tool for further investigation of the nature of the subcellular compartments and the molecular modifications involved in the multiple steps involved in internalization of G protein-coupled receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271354     DOI: 10.1124/mol.52.2.306

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Receptor phosphorylation mediates estradiol reduction of alpha2-adrenoceptor coupling to G protein in the hypothalamus of female rats.

Authors:  M A Ansonoff; A M Etgen
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

2.  Smooth muscle and parasympathetic nerve terminals in the rat urinary bladder have different subtypes of alpha(1) adrenoceptors.

Authors:  E A Széll; T Yamamoto; W C de Groat; G T Somogyi
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

3.  A novel melanocortin-4 receptor gene mutation in a female patient with severe childhood obesity.

Authors:  Christian L Roth; Michael Ludwig; Joachim Woelfle; Zhen-Chuan Fan; Harald Brumm; Heike Biebermann; Ya-Xiong Tao
Journal:  Endocrine       Date:  2009-02-12       Impact factor: 3.633

4.  Cardiac hypertrophy in neonatal nephrectomized rats: the role of the sympathetic nervous system.

Authors:  Siddhartha S Ghosh; Richard J Krieg; Domenic A Sica; Ruipeng Wang; Itaf Fakhry; Todd Gehr
Journal:  Pediatr Nephrol       Date:  2008-09-17       Impact factor: 3.714

5.  Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptor.

Authors:  Chandramohan Natarajan; Aaron N Hata; Heidi E Hamm; Roy Zent; Richard M Breyer
Journal:  Mol Pharmacol       Date:  2012-10-18       Impact factor: 4.436

6.  Characterization of the alpha1-adrenoceptor subtype activating extracellular signal-regulated kinase in submandibular gland acinar cells.

Authors:  Michael R Bruchas; Myron L Toews; Charles S Bockman; Peter W Abel
Journal:  Eur J Pharmacol       Date:  2007-10-02       Impact factor: 4.432

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.